Additional file 5 of Elevated KRAS protein level is associated with better survival in pancreatic cancer

Additional file 5 of Elevated KRAS protein level is associated with better survival in pancreatic cancer

Additional file 5. Associations between clinicopathological variables and KRAS status and overall survival in patients with PDAC. Description: Univariable Cox Regression model for patients with PDAC (N=36). Three patients without overlapping protein and mRNA data, one patient with metastasis at diag...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: S. M. Stålberg (21641786) (author)
مؤلفون آخرون: L. Silwal-Pandit (21641789) (author), J. Hamfjord (21641792) (author), D. J. H. Nebdal (21641795) (author), J. Lehtiö (21641798) (author), O. C. Lingjærde (21641801) (author), B. S. Skålhegg (21641804) (author), E. H. Kure (21641807) (author)
منشور في: 2025
الموضوعات:
Biophysics
Biochemistry
Cell Biology
Genetics
Molecular Biology
Pharmacology
Cancer
Biological Sciences not elsewhere classified
Mathematical Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
Pancreatic cancer
PDAC
KRAS protein level
KRAS mRNA expression
KRAS mutation
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
الوصف
الملخص:Additional file 5. Associations between clinicopathological variables and KRAS status and overall survival in patients with PDAC. Description: Univariable Cox Regression model for patients with PDAC (N=36). Three patients without overlapping protein and mRNA data, one patient with metastasis at diagnosis, and one patient with non-standard treatment were excluded from the analysis. P-values < 0.05 are in bold. CI=Confidence Interval. * One patient with a tumor with high differentiation is not illustrated in this table. ** No CA19-9 values prior to surgery were registered for 17 of the 36 patients.

مواد مشابهة